Study of effectiveness of propofol dosage in prevention of nausa and vomiting in some surgeris

Study and comparison of two different doses of propofol in prevention of nausea and vomiting in spinal discectomy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160307026950N21

Enrollment

Registered

2020-06-29

Start date

2018-03-21

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Nausea. Condition 2: Vomit.

Interventions

Intervention 1: Intervention group 1: First, patients are given the necessary information about the type of operation and sedation method, and written consent is obtained from each of them. Vital symp

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The person should not have received any sedative or narcotic drugs No gastrointestinal problems such as reflux Patients should be between 18 and 65 years old. Having a informed consent to enter the research

Exclusion criteria

Exclusion criteria: If there is any change in the relaxation method and the change in the surgical method, the patient should be excluded from the study. The patient's age is more than 65 years The patient's age is less than 18 years

Design outcomes

Primary

Measure	Time frame
Nausea score based on VAS criteria. Timepoint: During recovery time after surgery. Method of measurement: questionnaire.;To vomit or not to vomit. Timepoint: During recovery time after surgery. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamin Mohammadi

Esfahan University of Medical Sciences

saminmhmd@gmail.com+98 31 3624 8494

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026